Found: 80
Select item for more details and to access through your institution.
Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Management of Patients With Muscle-Invasive and Metastatic Bladder Cancer.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 10, p. 1333
- By:
- Publication type:
- Article
A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013.
- Published in:
- Journal of Patient-Reported Outcomes, 2020, v. 4, n. 1, p. 1, doi. 10.1186/s41687-020-00220-x
- By:
- Publication type:
- Article
Ovarian Function Suppression in Premenopausal Women With Concurrent Endocrine Therapy Use.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 4, p. 454, doi. 10.1016/j.clbc.2023.03.009
- By:
- Publication type:
- Article
Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Associations Between Patient and Anthropometric Characteristics and Aromatase Inhibitor Discontinuation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer.
- Published in:
- Frontiers in Genetics, 2021, v. 11, p. 1, doi. 10.3389/fgene.2021.662734
- By:
- Publication type:
- Article
Polypharmacy, over-the-counter medications, and aromatase inhibitor adherence in early-stage breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 204, n. 3, p. 539, doi. 10.1007/s10549-023-07218-1
- By:
- Publication type:
- Article
Breast cancer survivorship and sexual dysfunction: a population-based cohort study.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 200, n. 1, p. 103, doi. 10.1007/s10549-023-06953-9
- By:
- Publication type:
- Article
Association between nociplastic pain and premature endocrine therapy discontinuation in breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 197, n. 2, p. 397, doi. 10.1007/s10549-022-06806-x
- By:
- Publication type:
- Article
Co-occurrence and metabolic biomarkers of sensory and motor subtypes of peripheral neuropathy from paclitaxel.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 194, n. 3, p. 551, doi. 10.1007/s10549-022-06652-x
- By:
- Publication type:
- Article
Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 187, n. 1, p. 287, doi. 10.1007/s10549-020-06071-w
- By:
- Publication type:
- Article
Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 180, n. 3, p. 707, doi. 10.1007/s10549-020-05584-8
- By:
- Publication type:
- Article
Exemestane may be less detrimental than letrozole to bone health in women homozygous for the UGT2B17*2 gene deletion.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 2, p. 297, doi. 10.1007/s10549-019-05158-3
- By:
- Publication type:
- Article
Factors influencing the use of extended adjuvant endocrine therapy.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 181, doi. 10.1007/s10549-019-05145-8
- By:
- Publication type:
- Article
Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 172, n. 3, p. 603, doi. 10.1007/s10549-018-4946-0
- By:
- Publication type:
- Article
Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 3, p. 657, doi. 10.1007/s10549-018-4862-3
- By:
- Publication type:
- Article
Factors influencing scalp cooling discussions and use at a large academic institution: a single-center retrospective review.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 10, p. 8349, doi. 10.1007/s00520-022-07285-y
- By:
- Publication type:
- Article
Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 10, p. 8059, doi. 10.1007/s00520-022-07243-8
- By:
- Publication type:
- Article
Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: a qualitative study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Integrative Oncology Education: An Emerging Competency for Oncology Providers.
- Published in:
- Current Oncology, 2021, v. 28, n. 1, p. 853, doi. 10.3390/curroncol28010084
- By:
- Publication type:
- Article
Onchocerciasis in a Nonendemic Population: Clinical and Immunologic Assessment before Treatment and at the Time of Presumed Cure.
- Published in:
- Journal of Infectious Diseases, 2001, v. 183, n. 3, p. 512, doi. 10.1086/318088
- By:
- Publication type:
- Article
Interacciones farmacológicas y farmacogenómicas en el tratamiento de cáncer de mama y depresión.
- Published in:
- American Journal of Psychiatry - Edición Española, 2009, v. 12, n. 1, p. 11
- By:
- Publication type:
- Article
Correction to: Impact of the Integrative Oncology Scholars Program on Oncology Providers' Key Knowledge of Dietary Supplements and Antioxidants for Providing Evidence-based Oncology Care.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Impact of the Integrative Oncology Scholars Program on Oncology Providers' Key Knowledge of Dietary Supplements and Antioxidants for Providing Evidence-based Oncology Care.
- Published in:
- Journal of Cancer Education, 2023, v. 38, n. 6, p. 1871, doi. 10.1007/s13187-023-02348-y
- By:
- Publication type:
- Article
A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol.
- Published in:
- Technology in Cancer Research & Treatment, 2022, v. 21, p. 1, doi. 10.1177/15330338221127169
- By:
- Publication type:
- Article
CYP2D6 Testing for Breast Cancer Patients: Is There More to the Story?
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1236
- By:
- Publication type:
- Article
Complexities of Adjuvant Endocrine Therapy in Young Premenopausal Women.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 6, p. 482
- By:
- Publication type:
- Article
Aromatase Inhibitor—Associated Musculoskeletal Symptoms: Etiology and Strategies for Management.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 12, p. 1401
- By:
- Publication type:
- Article
Use of Gene-Expression Profiling to Recommend Adjuvant Chemotherapy for Breast Cancer.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 11, p. 1301
- By:
- Publication type:
- Article
Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 94, n. 2, p. 311, doi. 10.1007/s00280-024-04680-6
- By:
- Publication type:
- Article
Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor–Related Joint Pain: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 11, p. e2241720, doi. 10.1001/jamanetworkopen.2022.41720
- By:
- Publication type:
- Article
Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor–Associated Musculoskeletal Symptoms.
- Published in:
- JNCI Cancer Spectrum, 2021, v. 5, n. 6, p. 1, doi. 10.1093/jncics/pkab087
- By:
- Publication type:
- Article
Adverse Events and Perception of Benefit From Duloxetine for Treating Aromatase Inhibitor-Associated Arthralgias.
- Published in:
- JNCI Cancer Spectrum, 2021, v. 5, n. 2, p. 1, doi. 10.1093/jncics/pkab018
- By:
- Publication type:
- Article
Disparities in Cardiovascular Disease Risk Among Hispanic Breast Cancer Survivors in a Population-Based Cohort.
- Published in:
- JNCI Cancer Spectrum, 2021, v. 5, n. 2, p. 1, doi. 10.1093/jncics/pkab016
- By:
- Publication type:
- Article
Toronto Workshop on Late Recurrence in Estrogen Receptor–Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations.
- Published in:
- JNCI Cancer Spectrum, 2019, v. 3, n. 4, p. N.PAG, doi. 10.1093/jncics/pkz050
- By:
- Publication type:
- Article
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions.
- Published in:
- JNCI Cancer Spectrum, 2019, v. 3, n. 4, p. N.PAG, doi. 10.1093/jncics/pkz049
- By:
- Publication type:
- Article
327 Nociplastic pain and early discontinuation of aromatase inhibitor therapy in breast cancer patients over age 65.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Muscle mass affects paclitaxel systemic exposure and may inform personalized paclitaxel dosing.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 7, p. 3222, doi. 10.1111/bcp.15244
- By:
- Publication type:
- Article
Genetic variation in EPHA contributes to sensitivity to paclitaxel‐induced peripheral neuropathy.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 5, p. 880, doi. 10.1111/bcp.14192
- By:
- Publication type:
- Article
Exploring Adolescent and Young Adult Cancer Survivors' Experience with Cancer Treatment-Related Symptoms: A Qualitative Analysis of Semi-Structured Interviews.
- Published in:
- Journal of Adolescent & Young Adult Oncology, 2024, v. 13, n. 4, p. 665, doi. 10.1089/jayao.2024.0053
- By:
- Publication type:
- Article
Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 161, n. 3, p. 453, doi. 10.1007/s10549-016-4077-4
- By:
- Publication type:
- Article
Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negative metastatic breast cancer refractory to a non-steroidal aromatase inhibitor.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 154, n. 2, p. 287, doi. 10.1007/s10549-015-3615-9
- By:
- Publication type:
- Article
Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 117, n. 3, p. 571, doi. 10.1007/s10549-009-0309-1
- By:
- Publication type:
- Article
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 111, n. 2, p. 365, doi. 10.1007/s10549-007-9774-6
- By:
- Publication type:
- Article
Disparities in cancer survival and incidence by metropolitan versus rural residence in Utah.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 4, p. 1490, doi. 10.1002/cam4.1382
- By:
- Publication type:
- Article
Value-of-Information Analysis within a Stakeholder-Driven Research Prioritization Process in a US Setting: An Application in Cancer Genomics.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Efficacy/Safety of Talazoparib or Physician's Choice of Therapy in US Patients with HER2-Negative Germline BRCA1/2-Mutated Locally Advanced/Metastatic Breast Cancer (EMBRACA).
- Published in:
- Journal of Oncology Navigation & Survivorship, 2019, v. 10, n. 11, p. 501
- By:
- Publication type:
- Article
Risk of Toxicity From Topical 5‐Fluorouracil Treatment in Patients Carrying DPYD Variant Alleles.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 452, doi. 10.1002/cpt.3131
- By:
- Publication type:
- Article
Confirmatory DPYD Testing in Patients Receiving Fluoropyrimidines Who are Suspected DPYD Variant Carriers Based on a Genetic Data Repository.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 356, doi. 10.1002/cpt.2936
- By:
- Publication type:
- Article